Cargando…
Basics for Improved Use of Phages for Therapy
Blood-borne therapeutic phages and phage capsids increasingly reach therapeutic targets as they acquire more persistence, i.e., become more resistant to non-targeted removal from blood. Pathogenic bacteria are targets during classical phage therapy. Metastatic tumors are potential future targets, du...
Autores principales: | Serwer, Philip, Wright, Elena T., De La Chapa, Jorge, Gonzales, Cara B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234457/ https://www.ncbi.nlm.nih.gov/pubmed/34208477 http://dx.doi.org/10.3390/antibiotics10060723 |
Ejemplares similares
-
A Perspective on Studies of Phage DNA Packaging Dynamics
por: Serwer, Philip
Publicado: (2022) -
High murine blood persistence of phage T3 and suggested strategy for phage therapy
por: Serwer, Philip, et al.
Publicado: (2019) -
Nanomedicine and Phage Capsids
por: Serwer, Philip, et al.
Publicado: (2018) -
Enhancing and initiating phage-based therapies
por: Serwer, Philip, et al.
Publicado: (2014) -
In-Gel Isolation and Characterization of Large (and Other) Phages
por: Serwer, Philip, et al.
Publicado: (2020)